Mazor Robotics Ltd – ADR (MZOR) reported quarterly earnings results on Tuesday, Aug-2-2016. The company said it had a profit of $-0.09 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.01. Analysts had a consensus of $-0.10. The company posted revenue of $8.30 million in the period, compared to analysts expectations of $8.51 million. The company’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.05 EPS.
Many Wall Street Analysts have commented on Mazor Robotics Ltd – ADR. Standpoint Research Initiated Mazor Robotics Ltd – ADR on Jul 8, 2016 to “Buy”, Price Target of the shares are set at $30.Mazor Robotics Ltd – ADR was Downgraded by Sterne Agee CRT to ” Neutral” on May 31, 2016. Mazor Robotics Ltd – ADR was Upgraded by Wells Fargo to ” Outperform” on May 19, 2016.
Mazor Robotics Ltd – ADR opened for trading at $22.5 and hit $23.18 on the upside on Friday, eventually ending the session at $22.66, with a gain of 2.39% or 0.53 points. The heightened volatility saw the trading volume jump to 3,02,308 shares. Company has a market cap of $482 M.
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System which enables surgeons to advance from freehand surgical procedures to guided procedures as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System used in spine surgeries whether open or minimally invasive for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries including fusion correction of spinal deformities biopsy collection tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.